CN
487-69-4
应用筛选条件
关键词:'487-69-4'
显示 1-27 共 27 条结果 关于 "487-69-4" 范围 技术文档
Quality Control Range Sheet- HSTC-108 and HSTC-208
32 pg/mL IL-17A Control 1 17 – 35 pg/mL
Control 2 57 – 119 pg/mL Control 2 69 – 143 pg/mL
IL-4 Control
Data Sheet - H4664
(2001).
7. Wu, X., et al., Oncogene, 24, 4728-4735 (2005).
8. Hang, H., et al., Genomics, 79, 487-492 (2002).
YK,NV, KAA,PHC 03/06-1
Sigma brand
Data Sheet - S5687
Science, 260, 487-489 (1993).
4. Bennett, M.K. and Scheller, R., Proc. Natl. Acad.
Sci. (USA), 90, 2559-2563 (1993).
5. Hirai, Y. et al., Cell, 73, 426 -427 (1993).
6. Hirai, Y. et al., Cell, 69, 471-481
Optimize Your Cross-Coupling: The Phosphine Predictor
NEt2
Et2N
Et2N 2283-11-6 253189
458 PPh2(1-Isochinolin-2-Nap)
N
PPh2
149245-03-4 779911
487 Bis[4-(3,3,4,4,5,5,5-heptafluoro-2,2-
bis(trifluoromethyl) pentyl)phenyl]
phenylphosphine
P
Product Information Sheet - MAK330
aspartate, glutamate, and γ--
aminobutyrate in nerve tissue using enzymic
methods. Anal. Biochem., 15, 487-497 (1966).
TWEEN is a registered trademark of Croda
International PLC
HM,MAM 11/18-1
XP725 Antibody Number-Lot Number 071M4826
456 477 478 479 480
6.1 481 482 483 484 505 506 507 508 529 530 531 532 553 554 555 556
6.2 485 486 487 488 509 510 511 512 533 534 535 536 557 558 559 560
6.3 489 490 491
Product Information Sheet - CS0550
Expected
Neat 24 24 100
1:2 11 12 94
1:4 6 6 100
1:8 3.8 3 127
Specificity
• The specificity of this assay for Phospho-ATF
phosphorylated on threonine 69 and 71 was
Product Information Sheet - CS0540
threonines 69 and 71 increased in HeLa cells upon
anisomycin treatment.
• Recombinant protein phosphorylated by JNK2
showed dramatic increase in ATF2 [pThr69/pThr71].
8
Figure 4
Fluorescent Calcium Probes Technical Bulletin
Brunkhorst, B.A., et al. 1991. J. Biol. Chem. 266, 13035; Wahl, M., et al. 1990.
Cell Calcium 11, 487.
Cat. No. 402095-Y 1 mg
5 mg
INDO 1/AM. A cell-permeable ester derivative of INDO 1. It
is rapidly
Anti-NeuN, clone A60 - Data Sheet
544.
67) Peretto, P., et al., J. Comparative Neurology (2005) 487:407-427.
68) Scheffler, B., et al., PNAS (2005) 102:9353-9358.
69) Yang, P., et al., J. Comparative Neurology (2005) 490:163-179.
Product Information Sheet - S0501
Anal. Profiles of Drug Subs., K. Florey, ed. Academic Press, NY, 6, 487, 1977.
3. Frank, M.J., et al., J. Pharm. Sci., 65, 44, 1976.
4. Bult, A., et al., Anal. Profiles of Drug Subs., K. Florey, ed. Academic
Balancing Histone/Protein Acetylation-Gene Regulation and Cancer Therapy
, 495-528
(2005).
68. Chiba, T., et al., J. Hepatol., 41, 436-445 (2004).
69. Marks, P.A. and Jiang, X., Cell Cycle, 4, 549-551 (2005).
70. Taunton, J., et al., Science, 272, 408-411 (1996).
71.
Bulletin - MOUSEVS
Primer-directed enzymatic amplification of DNA with a thermostable DNA
polymerase. Science 239 (4839), 487-491 (1988).
Sambrook, J., et al. Molecular Cloning: A Laboratory Manual, third edition, Cold Spring
Bulletin - RATVS
Primer-directed enzymatic amplification of DNA with a thermostable DNA
polymerase. Science 239 (4839), 487-491 (1988).
Sambrook, J., et al. Molecular Cloning: A Laboratory Manual, third edition, Cold Spring
Research Article: MCP-1, KC-like and IL-8 as critical mediators of
cytokine-treated human lung epithelial cells by thiazolidinedione. Chest. 2001;
120(4):1293–300. PMID: 11591574
69. Baeck C WA, Karlmark KR, Heymann F, Vucur M, Gassler N, Huss S, et al. Pharmacological
XP725 Antibody List Lot 089K4791
R3777 4670 HNRNPM M NP_005959.2 y y y
486 NBS1 (Nibrin) N9287 4683 NBN M NP_002476.2 y n/d n/d
487 NBS1 (Nibrin) N3037 4683 NBN P NP_002476.2 y n/d n/d
488 NBS1 (Nibrin) N3162 4683 NBN P NP_002476.2
XP725 Antibody List Lot 129K4831
R3777 4670 HNRNPM M NP_005959.2 y y y
486 NBS1 (Nibrin) N9287 4683 NBN M NP_002476.2 y n/d n/d
487 NBS1 (Nibrin) N3037 4683 NBN P NP_002476.2 y n/d n/d
488 NBS1 (Nibrin) N3162 4683 NBN P NP_002476.2
XP725 Antibody List Lot 129K4830
R3777 4670 HNRNPM M NP_005959.2 y y y
486 NBS1 (Nibrin) N9287 4683 NBN M NP_002476.2 y n/d n/d
487 NBS1 (Nibrin) N3037 4683 NBN P NP_002476.2 y n/d n/d
488 NBS1 (Nibrin) N3162 4683 NBN P NP_002476.2
Halal Certificate
485. CIS-3-HEXENYL TIGLATE W393118 C44276 HC-23SISF90
486. CIS-4-DECENAL 93%, STABILIZED W326402 B21092 HC-23SIYP97
487. CIS-4-HEPTENAL 98%, FCC, FG W328901 B60926 HC-23SIJI64
488. CIS-5-OCTEN
Halal Certificate
485. CIS-3-HEXENYL TIGLATE W393118 C44276 HC-22SI5712
486. CIS-4-DECENAL 93%, STABILIZED W326402 B21092 HC-22SI8Q19
487. CIS-4-HEPTENAL 98%, FCC, FG W328901 B60926 HC-22SIEM85
488. CIS-5-OCTEN
List of Antibodies
y
484 Myosin VI M0691 M y y y
485 Myosin VI M5187 P n/d n/d y
486 NBS1 (Nibrin) N9287 M y n/d n/d
487 NBS1 (Nibrin) N3037 P y n/d n/d
488 NBS1 (Nibrin) N3162 P y n/d y
489 Nck-2 N2911 M y
XP725 Worksheet for Lot Number 071M4826
3 1 4 E2F2 E8776
485 3 3 1 5 E2F3 E8651
486 3 3 1 6 E2F3 E8651
487 3 3 1 7 E2F4 E8526
488 3 3 1 8 E2F4 E8526
489 3 3 2 1 E6AP E8655
490 3 3 2 2 E6AP
Brochure: Chromolith® Monolithic Silica HPLC Columns for small and large molecule separation
as a solvent
(See Analysis Note for more information)
Sample: Metamitron 159 mg/L, Carbetamid 487 mg/L,
Prometryn 60 mg/L, Carbofuran 548 mg/L,
Isoproturon 159 mg/L, Metazachlor 796 mg/L,
Metolachlor
3D BIOPRINTING: Printing a Brighter Future
Tashman, J.; Hinton, T.; Yerneni, S.;
Bliley, J.; Campbell, P.; Feinberg, A. Science 2019, 365, 482–487.
(54) Highley, C. B.; Rodell, C. B.; Burdick, J. A. Adv. Mater. 2015, 27, 5075–
5079.
(55) Yin
3D BIOPRINTING: Printing a Brighter Future
Tashman, J.; Hinton, T.; Yerneni, S.;
Bliley, J.; Campbell, P.; Feinberg, A. Science 2019, 365, 482–487.
(54) Highley, C. B.; Rodell, C. B.; Burdick, J. A. Adv. Mater. 2015, 27, 5075–
5079.
(55) Yin
XP725 Antibody List
VI M5187 4646 MYO6 NP_004990.3 P n/d n/d y
486 NBS1 (Nibrin) N9287 4683 NBN NP_002476.2 M y n/d n/d
487 NBS1 (Nibrin) N3037 85482, 27354, 4683 NBN,Nbn NP_620228.1,NP_038780.3,NP_002476.2 P y n/d n/d
488
XP725 Antibody List 013M4793
VI M5187 4646 MYO6 NP_004990.3 P n/d n/d y
486 NBS1 (Nibrin) N9287 4683 NBN NP_002476.2 M y n/d n/d
487 NBS1 (Nibrin) N3037 85482, 27354, 4683 NBN,Nbn NP_620228.1,NP_038780.3,NP_002476.2 P y n/d n/d
488